Stephen Todryk
Stephen Todryk
Professor of Immunology, Northumbria University
Verified email at
Cited by
Cited by
Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression
A Melcher, S Todryk, N Hardwick, M Ford, M Jacobson, RG Vile
Nature medicine 4 (5), 581-587, 1998
Suppression of antitumor immunity by IL-10 and TGF-β-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ …
AG Jarnicki, J Lysaght, S Todryk, KHG Mills
The journal of immunology 177 (2), 896-904, 2006
The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells
C Galustian, B Meyer, MC Labarthe, K Dredge, D Klaschka, J Henry, ...
Cancer Immunology, Immunotherapy 58, 1033-1045, 2009
Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake
S Todryk, AA Melcher, N Hardwick, E Linardakis, A Bateman, ...
The Journal of Immunology 163 (3), 1398-1408, 1999
Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector
GA O’Hara, CJA Duncan, KJ Ewer, KA Collins, SC Elias, FD Halstead, ...
Journal of Infectious Diseases 205 (5), 772-781, 2012
Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15
J Dunne, S Lynch, C O’Farrelly, S Todryk, JE Hegarty, C Feighery, ...
The Journal of Immunology 167 (6), 3129-3138, 2001
Protective antitumor immunity induced by a costimulatory thalidomide analog in conjunction with whole tumor cell vaccination is mediated by increased Th1-type immunity
K Dredge, JB Marriott, SM Todryk, GW Muller, R Chen, DI Stirling, ...
The Journal of Immunology 168 (10), 4914-4919, 2002
A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya
P Bejon, J Mwacharo, O Kai, T Mwangi, P Milligan, S Todryk, S Keating, ...
PLoS clinical trials 1 (6), e29, 2006
Facets of heat shock protein 70 show immunotherapeutic potential
SM Todryk, MJ Gough, AG Pockley
Immunology 110 (1), 1-9, 2003
Immunotherapeutic potential of whole tumour cells
S Ward, D Casey, MC Labarthe, M Whelan, A Dalgleish, H Pandha, ...
Cancer Immunology, Immunotherapy 51, 351-357, 2002
Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen‐specific Th1 and enhancement of Th2 …
P Byrne, P McGuirk, S Todryk, KHG Mills
European journal of immunology 34 (9), 2579-2588, 2004
Apoptosis or necrosis for tumor immunotherapy: what's in a name?
A Melcher, M Gough, S Todryk, R Vile
Journal of molecular medicine 77, 824-833, 1999
Heat shock proteins refine the danger theory
SM Todryk, AA Melcher, AG Dalgleish, RG Vile
Immunology 99 (3), 334, 2000
Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against …
SM Keating, P Bejon, T Berthoud, JM Vuola, S Todryk, DP Webster, ...
The Journal of Immunology 175 (9), 5675-5680, 2005
Adjuvants and the promotion of Th1-type cytokines in tumour immunotherapy
K Dredge, BJ Marriott, SM Todryk, AG Dalgleish
Cancer Immunology, Immunotherapy 51, 521-531, 2002
An intelligent decision support system for leukaemia diagnosis using microscopic blood images
S Chin Neoh, W Srisukkham, L Zhang, S Todryk, B Greystoke, ...
Scientific reports 5 (1), 14938, 2015
A synthetic peptide adhesion epitope as a novel antimicrobial agent
CG Kelly, JS Younson, BY Hikmat, SM Todryk, M Czisch, PI Haris, ...
Nature biotechnology 17 (1), 42-47, 1999
Intelligent leukaemia diagnosis with bare-bones PSO based feature optimization
W Srisukkham, L Zhang, SC Neoh, S Todryk, CP Lim
Applied soft computing 56, 405-419, 2017
Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial
FM Thompson, DW Porter, SL Okitsu, N Westerfeld, D Vogel, S Todryk, ...
PLoS One 3 (1), e1493, 2008
Heat shock protein peptides reactive in patients with Behcet's disease are uveitogenic in Lewis rats
MR Stanford, E Kasp, R Whiston, A Hasan, S Todryk, T Shinnick, ...
Clinical & Experimental Immunology 97 (2), 226-231, 1994
The system can't perform the operation now. Try again later.
Articles 1–20